13F filer · CIK 200406
JOHNSON & JOHNSON
NEW BRUNSWICK, NJ · filing since Q3 2021 · last filing Oct 26, 2026
Reported value
$761.7M
$-37.0M vs prior
Positions
15
New / sold out
0 / 0
Added / reduced
1 / 0
Turnover
0.0%
buys $13.3M · sells $0
Top-10 weight
98.8%
Biggest buys vs Q2 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Added | CEREBRAS SYSTEMS INC | +75,063 | +140.1% | +$13.3M |
Biggest sells vs Q2 2026
No reduced or sold positions this quarter.
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q3 2026
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | PROTAGONIST THERAPEUTICS INCCOM | 2,449,183 | $345.1M | 45.30% |
| 2 | NANOBIOTIXSPONSORED ADS | 5,623,816 | $175.2M | 23.01% |
| 3 | MEIRAGTX HLDGS PLCCOM | 6,641,064 | $73.1M | 9.59% |
| 4 | RAPPORT THERAPEUTICS INCCOM | 1,784,517 | $60.0M | 7.87% |
| 5 | CONTINEUM THERAPEUTICS INCCL A | 1,979,173 | $26.6M | 3.49% |
| 6 | CEREBRAS SYSTEMS INCCOM CL A | 128,649 | $22.9M | 3.00% |
| 7 | XENCOR INCCOM | 748,062 | $18.7M | 2.45% |
| 8 | LEGEND BIOTECH CORPSPONSORED ADS | 814,586 | $16.2M | 2.13% |
| 9 | FATE THERAPEUTICS INCCOM | 3,379,064 | $8.0M | 1.05% |
| 10 | CVRX INCCOM | 4,024,861 | $7.0M | 0.92% |
5 more rows. Subscribe for $29/month to see every row, download the data and use the API.